Bellicum Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Bellicum Pharmaceuticals patents 12 in total
Status | Patent |
---|---|
Application | Utility: IMPROVED FORMULATIONS FOR IMMUNE CELLS Filling date: 8 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS Filling date: 8 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS Filling date: 8 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: PSCA CAR-T CELLS Filling date: 8 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: T CELLS WITH SUICIDE SWITCH Filling date: 8 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES Filling date: 8 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: METHODS TO AUGMENT OR ALTER SIGNAL TRANSDUCTION Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: NATURAL KILLER CELL PRODUCTS AND METHODS Filling date: 8 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY Filling date: 8 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: Multimeric piperidine derivatives Filling date: 8 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES Filling date: 8 Sep 2025 Issue date: 23 Jul 2020 |
Showing 1 to 12 of 12 patents.